Bladder Carcinoma

• CLINICAL_TRIALS research · 2026-03-10
  Clinical Trial Update: Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

  A Mayo Clinic-sponsored clinical trial is actively recruiting to evaluate health-related quality of life and urinary outcomes after partial …

• CLINICAL_TRIALS trial_result · 2023-11-24
  Clinical Trial Update: First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma [Phase 2]

  Phase 2 trial evaluating first-line everolimus with or without paclitaxel in cisplatin-ineligible advanced urothelial carcinoma was terminat…

• CLINICAL_TRIALS trial_result · 2021-02-25
  Clinical Trial Update: TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer [NA]

  A completed clinical trial evaluating TracelT Hydrogel for localizing bladder tumors in patients undergoing radiation therapy for bladder ca…

• CLINICAL_TRIALS trial_result · 2021-02-25
  Clinical Trial Update: hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" [Phase 2]

  Phase 2 trial update investigating cabozantinib and durvalumab in bladder carcinoma (ARCADIA study) with status currently UNKNOWN.

• CLINICAL_TRIALS trial_result · 2019-06-04
  Clinical Trial Update: Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy [Phase 2, Phase 3]

  Phase 2/3 clinical trial evaluating gabapentin to reduce postoperative pain medication use in bladder cancer patients undergoing radical cys…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-03-24
  Clinical Trial Update: Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer [Phase 2]

  A Phase II study of Genistein (Isoflavone G-2535) in bladder cancer has completed and results were posted in 2016.